Filana Therapeutics Inc.
FLNA | NASDAQ
$0.62
-$0.04 (-5.78%)
At close: Oct 30, 2026, 4:00 PM ET
$0.65
+$0.03 (+4.95%)
Pre-market:
Nov 2, 2026, 7:51 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
PE Ratio | -1.09 | -3.87 | -0.88 | -1.08 | -2.50 |
PEG Ratio | 0 | 0.05 | -0.04 | -0.01 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.33 | n/a | n/a | n/a | n/a |
P/FCF Ratio | -3.02 | n/a | n/a | n/a | n/a |
P/OCF Ratio | -3.07 | n/a | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 2.23 | n/a | n/a | n/a | n/a |
Current Ratio | 2.23 | n/a | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -122.27% | n/a | n/a | n/a | n/a |
Return on Assets | -76.86% | n/a | n/a | n/a | n/a |
Return on Invested Capital | -128% | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove FLNA